Medications

FDA approves IV artesunate for severe malaria

Intravenous (IV) artesunate received approval from the U.S. Food and Drug Administration to treat adults and children with severe malaria, the agency announced Tuesday.

Diseases, Conditions, Syndromes

As US, Europe reopen more, big nations see rising virus toll

American car makers are getting back to work and Europe is continuing to reopen. But while new coronavirus cases have been declining in many countries that were initially hit hard by the pandemic, cases are rapidly rising ...

Diseases, Conditions, Syndromes

New evidence for optimizing malaria treatment in pregnant women

The research, published today in The Lancet Infectious Diseases is the fruit of joint project between investigators from around the world to conduct the largest individual patient data meta-analysis to date under the WWARN ...

Diseases, Conditions, Syndromes

FDA warns about treating COVID-19 with unproven drugs

(HealthDay)—Malaria drugs touted by some as potential "game changers" against COVID-19 are actually too dangerous for general use, the U.S. Food and Drug Administration warned Americans on Friday.

Medications

FDA warns of heart risks with Trump-promoted malaria drug

The U.S. Food and Drug Administration on Friday warned doctors against prescribing a malaria drug touted by President Donald Trump for treating the new coronavirus except in hospitals and research studies.

Diseases, Conditions, Syndromes

Malaria drugs' promise for coronavirus spurs hope, shortages

Excitement about treating the new coronavirus with malaria drugs is raising hopes, including with President Donald Trump. But the evidence that they may help is thin, and a run on the drugs is complicating access for people ...

page 8 from 25